Skip to main content
Chemical Science logoLink to Chemical Science
. 2019 Jan 31;10(12):3481–3485. doi: 10.1039/c8sc05618h

ppm Pd-catalyzed, Cu-free Sonogashira couplings in water using commercially available catalyst precursors

Bo Jin a, Fabrice Gallou b, John Reilly c, Bruce H Lipshutz a,
PMCID: PMC6438147  PMID: 30996938

graphic file with name c8sc05618h-ga.jpgA new catalyst that derives from commercially available precursors for copper-free, Pd-catalyzed Sonogashira reactions at the sustainable ppm level of precious metal palladium under mild aqueous micellar conditions has been developed.

Abstract

A new catalyst that derives from commercially available precursors for copper-free, Pd-catalyzed Sonogashira reactions at the sustainable ppm level of precious metal palladium under mild aqueous micellar conditions has been developed. Both the palladium pre-catalyst and ligand are commercially available, bench stable, and highly cost-effective. The catalyst is applicable to both aryl- and heteroaryl-bromides as educts. A wide range of functional groups are tolerated and the aqueous reaction medium can be recycled. An application to a key intermediate associated with an active pharmaceutical ingredient (ponatinib) is discussed.

Introduction

Development of a Pd-catalyzed process that leads to coupling between a terminal alkyne and an aromatic/heteroaromatic ring by Sonogashira and co-workers back in 1975 (ref. 1) focused on providing an alternative to the corresponding reaction mediated solely by copper, the Castro–Stevens coupling. Today, Sonogashira couplings no longer require use of both catalytic Pd and Cu; rather, catalytic Pd alone is quite sufficient when appropriately complexed by a ligand more modern than the Ph3P originally employed. Among the array of highly valued Pd-catalyzed coupling reactions, Sonogashira couplings remain unique due to the involvement of an sp carbon center, and are widely utilized in the pharmaceutical industry2 and in natural products total synthesis,3 as well as in the construction of organic materials.4 Nonetheless, improvements continue, looking to enhance functional group tolerance and yields, avoidance of occasional harsh reaction conditions and problematic workups, as well as avoidance of more expensive and sensitive coupling partners (e.g., iodides).2c,5 Also looming big is the up front cost of Pd catalysts and associated expensive ligands, typically used in the 1–5 mol% range, while at the back end, required removal of residual metal embedded within the desired products is to be expected and must be removed especially when working towards an API.6 Moreover, from the environmental perspective, most Sonogashira couplings are run in organic solvents, without recycling of either the medium or precious metal catalyst.7 Use of these traditional reaction parameters dramatically increase levels of both the organic and aqueous waste to be expected, and fail to acknowledge the endangered status of platinoids.8

Previously, we disclosed a sustainable technology for ppm level Pd-catalyzed Sonogashira cross-couplings based on the new ligand HandaPhos, enabled by aqueous micellar catalysis.9 This approach reduces usage of Pd to a sustainable 1000 ppm (0.1 mol%) loading, without participation by copper. At issue, however, is the preparation of HandaPhos,10 following the sequence first outlined by Boehringer-Ingelheim,11 requiring 10 steps. Herein we describe an alternative technology that maintains the ppm level of palladium catalysis under aqueous micellar conditions, but which benefits from readily available precursors that are items of commerce and hence, makes this approach more accessible and far more economically attractive.

Results and discussion

Based on our earlier work describing room temperature Sonogashira reactions in aqueous nanoreactors derived from the designer surfactant PTS,12 we re-examined the BRIDP family of ligands developed by Takasago.13 Screening initially at 1300 ppm (0.13 mol%) of various sources of Pd in 2nd generation micellar media (TPGS-750-M/H2O) indicated that, yet again, cBRIDP (Scheme 1) imparts the greatest reactivity (also see ESI).

Scheme 1. Structures of cBRIDP ligand, pre-catalyst [Pd(cinnamyl)Cl]2 and in situ-derived catalyst 1 used in this model reaction.

Scheme 1

The source of Pd was also crucial for Sonogashira couplings at the ppm level of this metal. Hence, increasing the lipophilicity of the allylic ligand on Pd (by going from allyl to crotyl to cinnamyl), presumably increasing the binding constant of this catalyst to the inner micellar core,14 afforded the most effective and active catalyst system. The increased bulkiness at the 1-position may also play an activating role by minimizing formation of less reactive Pd(i) dimeric species, as noted previously by Hazari15 and Colacot.16 The most effective combination ultimately led to use of a 3 : 1 ratio of ligand to palladium. K3PO4·H2O was found to be the best base for liquid starting materials. However, when the bromide or terminal alkyne is a solid, the resulting viscosity of the medium caused by the (solid) base was found to inhibit stirring. In this case the base could be readily changed to Et3N. From these reaction parameters, a variety of substrate combinations using 0.05 mol% of dimeric [PdCl(cinnamyl)]2 (i.e., 1000 ppm) was screened (Table 1(A)). At these low levels of handling, the catalyst was added to the reaction vial in the form of a pre-mixed THF stock solution, after which the small amounts of THF were easily removed under vacuum. For substrates that appeared to be more challenging (e.g., slower or incomplete reactions), 1500 ppm (0.15 mol%) of the same palladium pre-catalyst was found to be very effective (Table 1(B)).

Table 1. Representative Sonogashira couplings in water catalyzed by (A) 1000 or (B) 1500 ppm Pd a , b .

graphic file with name c8sc05618h-u1.jpg
graphic file with name c8sc05618h-u2.jpg

aConditions: bromide (0.5 mmol), [(cinnamyl)PdCl]2 (0.05 mol%), cBRIDP (0.30 mol%), terminal alkyne (0.60 mmol), K3PO4·H2O (2.0 equiv.), TPGS-750-M/H2O (2 wt%, 1 mL), 45 °C, Ar.

bIsolated yield.

cEt3N (2.0 equiv.) as base.

dReaction run at 35 °C, 1.1 equiv. of terminal alkyne used.

e1.5 equiv. of terminal alkyne used.

Judging from the results shown in Table 1, this new catalytic system displays high functional group compatibility. Heteroaryl bromides leading to 2-, 3-, and 4-substituted pyridines (3, 4, 8, 11, 19), quinoline (6), furan (5), benzothiophene (10), thiophene (15), and indole (16) were all converted to their corresponding coupling products in good-to-excellent yields. Similarly, sensitive functional groups are tolerant, as in products containing chloro (9, 11, 12, 14), enyne (3), fluoro (3, 5, 8, 9), trifluoromethyl (12, 20), ketone (4), aldehyde (5, 14, 15), thioether (2), amide (7), acetal (9, 17, 18), hydroxyl (6), ester (17, 19) and carbamate (16) residues. Product 13 could be readily generated in gram quantities (i.e., on a 5 mmol scale). Notably, this gram-scale reaction could be carried out with solid palladium pre-catalyst and ligand; i.e., without pre-dissolution in THF.

The products of these reactions17 produce alkynes attached to aromatic or heteroaromatic rings, which represent electron-withdrawing groups that may provide additional activation useful for secondary processes. For example, as illustrated in Scheme 2 below, a 2-step, 1-pot sequence, initiated by a Sonogashira cross-coupling, is then followed (without isolation or added base) by a selective SNAr reaction to install a diamine-containing residue common to many biologically active compounds.18 Both reactions take place in virtually quantitative yields to afford internal alkyne 23.

Scheme 2. 2-Step, 1-pot process using an initial 1000 ppm Pd-catalyzed Sonogashira coupling in water.

Scheme 2

At typical loadings of Pd in the 1–5 mol% range, residual amounts of Pd in the hundreds of ppm range are to be expected, requiring removal especially when associated with an API. Process chemists have developed systematic methods6,19 so as to meet FDA regulations for palladium allowance.20 ICP-MS tests indicated that products from these ppm level Pd-catalyzed Sonogashira couplings contain less than 1 ppm when run at a loading of 1000 ppm palladium (Scheme 3), amounts which are well below acceptable levels.

Scheme 3. ICP-MS analyses of residual palladium in products 4 and 11.

Scheme 3

Other features associated with this ppm Pd chemistry in water include the facile recycling of the aqueous TPGS-750-M solution being used, and the low E factor suggestive of the limited amounts of waste being created. Rather than using an “in flask” extraction process that requires only small amounts of an organic solvent, as done in our previous study,21 an even lower E factor can be achieved by simply filtering the solid product that precipitates out from the reaction. The aqueous filtrate containing the surfactant, engineered to remain in the water, can be collected and used for subsequent couplings. In these cases, the crude product was washed with small amounts of DI water and air-dried. Hence, the only organic solvent required for this reaction is THF, used to prepare the stock solution of catalyst. The resulting E factor based on this reaction, as a measure of “greenness”,22 is only 0.78 (see ESI). As indicated previously with respect to the gram-scale reaction, preparation of a stock solution is actually not necessary for this reaction, in which case the E factor goes to zero. The aqueous solution containing the surfactant was then recycled three times with the addition of 1000 ppm palladium plus ligand for each (see ESI), giving rise to consistently high isolated yields (Scheme 4).

Scheme 4. Recycling study and E factor determination.

Scheme 4

As an illustration of the potential for this coupling chemistry, a key intermediate 28 in the synthesis of the FDA approved tyrosine-kinase inhibitor ponatinib (Iclusig®).23 is shown in Scheme 5, involving two Sonogashira couplings. The starting material, bromide 24, was first coupled with TES-acetylene under standard reaction conditions using 750 ppm of the same catalyst derived from [PdCl(cinnamyl)]2 and cBRIDP. The TES group was then removed using a catalytic amount of potassium carbonate in a mixture of THF and methanol.24 The second Sonogashira coupling between the substituted phenylacetylene 26 and 3-iodoimidazo[1,2-b]pyridazine 27, readily prepared from imidazo[1,2-b]pyridazine upon treatment with NIS, proceeded smoothly under standard reaction conditions to afford intermediate 28 in excellent overall yield (77%). The targeted API was then realized by simple exposure of 28 to the aniline partner 29 in dry THF containing KO-t-Bu, following the procedure in the Takeda patent.25

Scheme 5. Synthesis of ponatinib. Conditions: step: (A) 24 (1.0 equiv.), (triethylsilyl)acetylene (2.0 equiv.), [(cinnamyl)PdCl]2 (0.075 mol%), cBRIDP (0.45 mol%), Et3N (2.0 equiv.), 0.5 M in 2 wt% TPGS-750-M/H2O, 45 °C, Ar, 45 h; step: (B) 25 (1.0 equiv.), K2CO3 (20 mol%), 0.5 M in 1 : 1 MeOH/THF, 45 °C, 5 h; step (C): imidazo[1,2-b]pyridazine (1.0 equiv.), N-iodosuccinimide (1.2 equiv.), 0.53 M in DMF, 80 °C, Ar, overnight; step (D): 27 (1.0 equiv.), 26 (1.2 equiv.), [(cinnamyl)PdCl]2 (0.075 mol%), cBRIDP (0.45 mol%), Et3N (2.0 equiv.), 0.5 M in 2 wt% TPGS-750-M/H2O, 45 °C, Ar, 47 h. Step (E): 28 (1.0 equiv.), 4-(4-methyl-piperazinomethyl)-3-(trifluoromethyl)aniline (1.0 equiv.), KO-t-Bu (2.0 equiv.), 0.17 M in THF, rt, Ar, 12 h.

Scheme 5

Conclusions

In summary, a sustainable, Cu-free, ppm level Pd-catalyzed Sonogashira reaction has been developed that represents the new ‘state-of-the-art’ in such valued cross-couplings, especially from the green chemistry perspective. It relies upon a combination of commercially available palladium pre-catalyst and ligand, leading to an in situ-formed highly active catalyst that is effective with aryl/heteroaryl halides at the 0.10–0.15 mol% level of endangered palladium at 45 °C in water as the reaction medium. Products can be isolated in many cases by simple filtration, thus entirely avoiding organic solvents throughout the process. In addition to documenting the potential for scale up, an application to a timely active pharmaceutical ingredient showcases this environmentally responsible and sustainable technology.

Conflicts of interest

There are no conflicts to declare.

Supplementary Material

Acknowledgments

Financial support provided by NSF (GOALI SusChEM 1566212) and Novartis is warmly acknowledged.

Footnotes

†Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc05618h

References

  1. . See also ; (a) Sonogashira K., Tohda Y., Hagihara N. Tetrahedron Lett. 1975;16:4467. [Google Scholar]; (b) New Trends in Cross-Coupling: Theory and Applications, ed. T. J. Colacot, RSC, Cambridge, UK, 2015. [Google Scholar]; (c) Metal-Catalyzed Cross-Coupling Reactions, ed. A. de Meijere and F. Diederich, Wiley-VCH, Weinheim, 2004, vol. 1 & 2. [Google Scholar]; (d) Seechurn C. C. C. J., Kitching M. O., Colacot T. J., Snieckus V. Angew. Chem., Int. Ed. 2012;51:5062. doi: 10.1002/anie.201107017. [DOI] [PubMed] [Google Scholar]
  2. (a) Wagner F. F., Comins D. L. J. Org. Chem. 2006;71:8673. doi: 10.1021/jo0616052. [DOI] [PubMed] [Google Scholar]; (b) Nishimura K., Kinugawa M. Org. Process Res. Dev. 2012;16:225. [Google Scholar]; (c) Sperry J. B., Farr R. M., Levent M., Ghosh M., Hoagland S. M., Varsolona R. J., Sutherland K. Org. Process Res. Dev. 2012;16:1854. [Google Scholar]; (d) Song Z. J., Tellers D. M., Dormer P. G., Zewge D., Janey J. M., Nolting A., Steinhuebel D., Oliver S., Devine P. N., Tschaen D. M. Org. Process Res. Dev. 2014;18:423. [Google Scholar]
  3. (a) López S., Fernandez-Trillo F., Midon P., Castedo L., Saa C. J. Org. Chem. 2006;71:2802. doi: 10.1021/jo052609u. [DOI] [PubMed] [Google Scholar]; (b) Manoni F., Rumo C., Li L., Harran P. G. J. Am. Chem. Soc. 2018;140:1280. doi: 10.1021/jacs.7b13591. [DOI] [PubMed] [Google Scholar]; (c) Zhou J., Gao B., Xu Z., Ye T. J. Am. Chem. Soc. 2016;138:6948. doi: 10.1021/jacs.6b03533. [DOI] [PubMed] [Google Scholar]; (d) Sowden M. J., Sherburn M. S. Org. Lett. 2017;19:636. doi: 10.1021/acs.orglett.6b03793. [DOI] [PubMed] [Google Scholar]
  4. (a) Idelson A., Sterzenbach C., Jester S.-S., Tschierske C., Baumeister U., Höger S. J. Am. Chem. Soc. 2017;139:4429. doi: 10.1021/jacs.6b13020. [DOI] [PubMed] [Google Scholar]; (b) Zhuang X., Gehrig D., Forler N., Liang H., Wagner M., Hansen M. R., Laquai F., Zhang F., Feng X. Adv. Mater. 2015;27:3789. doi: 10.1002/adma.201501786. [DOI] [PubMed] [Google Scholar]; (c) Narayana Y. S. L. V., Basak S., Baumgarten M., Mellen K., Chandrasekar R. Adv. Funct. Mater. 2013;23:5875. [Google Scholar]
  5. Kozell V., McLaughlin M., Strappaveccia G., Santoro S., Bivona L. A., Aprile C., Gruttadauria M., Vaccaro L. ACS Sustainable Chem. Eng. 2016;4:7209. [Google Scholar]
  6. Königsberger K., Chen G.-P., Wu R. R., Girgis M. J., Prasad K., Repič O., Blacklock T. J. Org. Process Res. Dev. 2003;7:733. [Google Scholar]
  7. (a) Chinchilla R., Nájera C. Chem. Rev. 2007;107:874. doi: 10.1021/cr050992x. [DOI] [PubMed] [Google Scholar]; (b) Chinchilla R., Nájera C. Chem. Soc. Rev. 2011;40:5084. doi: 10.1039/c1cs15071e. [DOI] [PubMed] [Google Scholar]
  8. Kooroshy J., Meindersma C., Podkolinski R., Rademaker M., Sweijs T., Diederen A., Beerthuizen M. and de Goede S., Scarcity of Minerals Hague Centre for Strategic Studies, Hague Centre for Strategic Studies, 2009. [Google Scholar]
  9. Handa S., Smith J. D., Zhang Y., Takale B. S., Gallou F., Lipshutz B. H. Org. Lett. 2018;20:542. doi: 10.1021/acs.orglett.7b03621. [DOI] [PubMed] [Google Scholar]
  10. Handa S., Andersson M. P., Gallou F., Reilly J., Lipshutz B. H. Angew. Chem., Int. Ed. 2016;55:4914. doi: 10.1002/anie.201510570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. (a) Tang W., Qu B., Capacci A. G., Rodriguez S., Wei X., Haddad N., Narayanan B., Ma S., Grinberg N., Yee N. K., Krishnamurthy D., Senanayake C. H. Org. Lett. 2010;12:176. doi: 10.1021/ol9025815. [DOI] [PubMed] [Google Scholar]; (b) Tang W., Capacci A. G., Wei X., Li W., White A., Patel N. D., Savoie J., Gao J. J., Rodriguez S., Qu B., Haddad N., Lu B. Z., Krishnamurthy D., Yee N. K., Senanayake C. H. Angew. Chem., Int. Ed. 2010;49:5879. doi: 10.1002/anie.201002404. [DOI] [PubMed] [Google Scholar]
  12. Lipshutz B. H., Chung D. W., Rich B. Org. Lett. 2008;10:3793. doi: 10.1021/ol801471f. [DOI] [PubMed] [Google Scholar]
  13. Suzuki K., Hori Y., Kobayashi T. Adv. Synth. Catal. 2008;350:652. [Google Scholar]
  14. Lipshutz B. H. Curr. Opin. Green Sustain. Chem. 2018;11:1. [Google Scholar]
  15. Hruszkewycz D. P., Balcells D., Guard L. M., Hazari N., Tilset M. J. Am. Chem. Soc. 2014;136:7300. doi: 10.1021/ja412565c. [DOI] [PubMed] [Google Scholar]
  16. DeAngelis A. J., Gildner P. G., Chow R., Colacot T. J. J. Org. Chem. 2015;80:6794. doi: 10.1021/acs.joc.5b01005. [DOI] [PubMed] [Google Scholar]
  17. In addition to the desired products from these couplings, it is also interesting to question the fate of the cinnamyl (cationic) residue within the Pd(ii) pre-catalyst 1 upon reduction under these reaction conditions.16 The most likely outcome, leading to trapping by water (and thus, producing cinnamyl alcohol), was in fact not observed (by careful GC analysis vs. an authentic sample). Rather, small amounts of the corresponding acetylated product (using phenyl-acetylene) were identified. This strongly suggests that the conversion of the catalyst 1 to its active Pd(0) state is taking place inside the hydrophobic micellar core, akin to that seen under traditional conditions in organic solvents,16 and not in the (hydrogen-bonded to water) PEG region or the surrounding aqueous medium
  18. (a) Lee N. R., Gallou F., Lipshutz B. H. Org. Process Res. Dev. 2017;21:218. [Google Scholar]; (b) Isley N. A., Linstadt R. T. H., Kelly S. M., Gallou F., Lipshutz B. H. Org. Lett. 2015;17:4734. doi: 10.1021/acs.orglett.5b02240. [DOI] [PubMed] [Google Scholar]
  19. (a) Urawa Y., Miyazawa M., Ozeki N., Ogura K. Org. Process Res. Dev. 2003;7:191. [Google Scholar]; (b) Huang J.-P., Chen X.-X., Gu S.-X., Zhao L., Chen W.-X., Chen F.-E. Org. Process Res. Dev. 2010;14:939. [Google Scholar]
  20. F.D.A., Q3D Elemental Impurities Guidance for Industry, https://www.fda.gov/downloads/drugs/guidances/ucm371025.pdf.
  21. Lipshutz B. H., Isley N. A., Fennewald J. C., Slack E. D. Angew. Chem., Int. Ed. 2013;52:10952. doi: 10.1002/anie.201302020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sheldon R. A. Green Chem. 2007;9:1273. [Google Scholar]
  23. Huang W.-S., Metcalf C. A., Sundaramoorthi R., Wang Y. H., Zou D., Thomas R. M., Zhu X. T., Cai L. S., Wen D., Liu S. Y., Romero J., Qi J. W., Chen I., Banda G., Lentini S. P., Das S., Xu Q. H., Keats J., Wang F., Wardwell S., Ning Y. Y., Snodgrass J. T., Broudy M. I., Russian K., Zhou T. J., Commodore L., Narasimhan N. I., Mohemmad Q. K., Iuliucci J., Rivera V. M., Dalgarno D. C., Sawyer T. K., Clackson T., Shakespeare W. C. J. Med. Chem. 2010;53:4701. doi: 10.1021/jm100395q. [DOI] [PubMed] [Google Scholar]
  24. Zhao Y., Slepkov A. D., Akoto C. O., McDonald R., Hegmann F. A., Tykwinski R. R. Chem.–Eur. J. 2005;11:321. doi: 10.1002/chem.200400822. [DOI] [PubMed] [Google Scholar]
  25. Murray C. K., Rozamus L. W., Chaber J. J., Sharma P. and Kazerani S., WO 2014/093583 A2, 2014.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Chemical Science are provided here courtesy of Royal Society of Chemistry

RESOURCES